A New Era of Cancer Care

Advances in science and technology have brought about a new wave of promising cancer…


Interview with Cheddar: Solving Unmet Need in Melanoma

I had the great privilege of speaking with Cheddar about the importance of cancer immunotherapy and…


sunset

A Patient’s Perspective

Immunotherapy is changing the way we perceive and treat cancer. Advances in science and technology…


Oncosec quarterly update

OncoSec Quarterly Update: July 2016

At OncoSec, we are committed to providing timely corporate updates, including recent achievements…


Spotlight on Cancer Moonshot 2020

Cancer Moonshot 2020 plans to break down barriers and enable progress by enhancing data access,…


OncoSec Summer Wrap-Up and Future Outlook

As the summer comes to an end, school begins, and the cool weather starts to set in, we wanted to…


OncoSec Rings Nasdaq Opening Bell

We were thrilled to participate in the Nasdaq Opening Bell Ceremony to celebrate our recent listing…


Upward and Onwards: OncoSec Moves to The NASDAQ Capital Market

On May 27th, we proudly announced that our common stock has been listed on The NASDAQ Capital…


Cancer immunotherapy is providing options for patients who are out of options

Established in 2011 by Punit Dhillon, OncoSec Medical Inc. is a San Diego-based biotechnology…